Tiandi Science & Technology (600582) Q1 2025 earnings summary

Executive summary

• Net profit attributable to shareholders surged 107.53% year-over-year to RMB 1.44 billion, despite an 8.09% decline in revenue to RMB 6.77 billion.

• Basic and diluted EPS both rose 107.78% year-over-year to RMB 0.347.

• Significant increase in investment income due to subsidiary equity transfer.

Financial highlights

• Operating cash flow was negative at -RMB 3.07 billion, down from -RMB 2.28 billion a year ago.

• Total assets grew 3.37% from year-end to RMB 59.19 billion; equity attributable to shareholders rose 5.94% to RMB 25.88 billion.

• Gross margin improved as cost reductions outpaced revenue decline.

• Investment income jumped to RMB 2.61 billion from RMB 43.7 million year-over-year.

Key financial ratios and metrics

• Weighted average ROE increased to 5.71% from 2.97% year-over-year.

• Net margin and EPS both more than doubled year-over-year.